FDA Inspection
RNA Bio/Pharma IncRNA Bio/Pharma Inc – FDA Inspection, Apr 11, 2025
Record Details
This FDA Inspection record concerns RNA Bio/Pharma Inc, with an inspection on April 11, 2025, issued by the Seattle District Office, covering human drugs.
- Office
- Seattle District Office
- Person
View Company Profile
ID · c7c1c61f-a078-481e-a9be-bf3a44e4cb45
Inspection Facts
Official Action Indicated (OAI)
Significant objectionable conditions were found and regulatory or administrative action is recommended.
- Inspection number
- 1266530
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
4- 21 CFR 211.110(a)Control procedures to monitor and validate performance
- 21 CFR 211.84(d)(2)Component identification test
- 21 CFR 211.22(a)Lack of quality control unit
- 21 CFR 211.166(c)(1)Homeopathic drugs, assessment of stability
Full citation text and observation details available on the Dashboard.
Other FDA inspections of RNA Bio/Pharma Inc
4| Date | Classification | Office | Project area |
|---|---|---|---|
| June 25, 2019 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 20, 2017 | NAI | Center for Food Safety and Applied Nutrition | Foodborne Biological Hazards |
| May 24, 2013 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| October 31, 2008 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for RNA Bio/Pharma Inc
- FDA Inspection 1097487 - 2019-06-25
- FDA Inspection 1030091 - 2017-09-20
- FDA Inspection 834118 - 2013-05-24
- FDA Inspection 546350 - 2008-10-31
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.